Although no drugs have been developed and clinical trials conducted for GDM using GCKR as a target, several existing lines of evidence suggest that improvements in insulin resistance and metabolic control with GCKR‐targeted interventions may exert a similar effect on the control of GDM. Here, INS is linked to gestational diabetes.